ESC 365 - Future direction for research in cardio-oncology.

ESC Premium Access

Future direction for research in cardio-oncology.

Session: Cardiac problems and related therapies for cancer patients

Topic: Cardiotoxicity of drugs

Speaker: Doctor D. Cardinale (Milan, IT)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Daniela Cardinale

European Institute of Oncology, Milan (Italy)

10 presentations

6 followers

4 more presentations in this session

State of the art in cardio-oncology.

Speaker: Professor J. Butler (Dallas, US)

Deletion of SIRT1 in the cardiomyocyte worsens doxorubicin-induced cardiac dysfunction in mice.

Speaker: Assistant Professor A. Kuno (Sapporo, JP)

A new approach: 24-hour holter electrocardiograms in cancer patients

Speaker: Mr M. Anker (Berlin, DE)

Protective effect of nebivolol on anthracycline-induced cardiotoxicity, assessed by tissue doppler velocities and by speckle tracking echocardiography

Speaker: Professor M. Tomescu (Timisoara, RO)

Access the full session

Cardiac problems and related therapies for cancer patients

Speakers: Doctor D. Cardinale, Professor J. Butler, Assistant Professor A. Kuno, Mr M. Anker, Professor M. Tomescu

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources